These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37644594)

  • 1. Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway.
    Feng G; Arima Y; Midorikawa K; Kobayashi H; Oikawa S; Zhao W; Zhang Z; Takeuchi K; Murata M
    Cancer Cell Int; 2023 Aug; 23(1):185. PubMed ID: 37644594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z; Li W; Ai J; Xie J; Zhang X
    J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
    Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
    J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of NACC1 inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via regulating the AKT/mTOR signaling pathway.
    Cao Z; Chen H; Mei X; Li X
    Oncol Lett; 2021 Dec; 22(6):828. PubMed ID: 34691255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma.
    Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J
    Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
    Liao H; Zhang L; Lu S; Li W; Dong W
    Front Genet; 2022; 13():848926. PubMed ID: 35812733
    [No Abstract]   [Full Text] [Related]  

  • 8. Tenascin-C promotes epithelial-to-mesenchymal transition and the mTOR signaling pathway in nasopharyngeal carcinoma.
    Cheng X; Li F; Tao Z
    Oncol Lett; 2021 Jul; 22(1):570. PubMed ID: 34113398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
    Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
    Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing c-Jun inhibits autophagy and abrogates radioresistance in nasopharyngeal carcinoma by activating the PI3K/AKT/mTOR pathway.
    Sun Y; Chen K; Lin G; Wan F; Chen L; Zhu X
    Ann Transl Med; 2021 Jul; 9(13):1085. PubMed ID: 34422997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0000523 regulates miR-1184/COL1A1/PI3K/Akt pathway to promote nasopharyngeal carcinoma progression.
    Huang P; Li M; Tang Q; Jiang K; Luo Y
    Apoptosis; 2022 Oct; 27(9-10):751-761. PubMed ID: 35759163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathway.
    Wu S; Cai W; Shi Z; Ming X; Yang X; Zhou Y; Chen X; Yang M
    Biochem Biophys Res Commun; 2022 Jul; 614():47-55. PubMed ID: 35567943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling.
    Pan S; Liang S; Wang X
    Life Sci; 2021 Aug; 278():119581. PubMed ID: 33961854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
    Wang X; Jin Q; Wang X; Chen W; Cai Z
    Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PNCK depletion inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells
    Xu Y; Wang J; Cai S; Chen G; Xiao N; Fu Y; Chen Q; Qiu S
    J Cancer; 2019; 10(27):6925-6932. PubMed ID: 31839828
    [No Abstract]   [Full Text] [Related]  

  • 17. Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway.
    Feng B; Chen K; Zhang W; Zheng Q; He Y
    J Clin Lab Anal; 2022 Dec; 36(12):e24720. PubMed ID: 36347827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YBX3 Mediates the Metastasis of Nasopharyngeal Carcinoma
    Fan X; Xie X; Yang M; Wang Y; Wu H; Deng T; Weng X; Wen W; Nie G
    Front Oncol; 2021; 11():617621. PubMed ID: 33816248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.
    Wang F; Xu WQ; Zhang WQ; Xu RC; Sun JL; Zhang GC; Liu ZY; Qi ZR; Dong L; Weng SQ; Shen XZ; Liu TT; Fang Y; Zhu JM
    Hepatol Int; 2024 Apr; 18(2):636-650. PubMed ID: 37982952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astaxanthin suppresses the malignant behaviors of nasopharyngeal carcinoma cells by blocking PI3K/AKT and NF-κB pathways via miR-29a-3p.
    Xu Y; Jiang C
    Genes Environ; 2024 Apr; 46(1):10. PubMed ID: 38649975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.